We are live on
!
Find out more
iBio
IBIO
IBIO
70 hedge funds and large institutions have $17.5M invested in iBio in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 33 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
15% more call options, than puts
Call options by funds: $260K | Put options by funds: $226K
0% less ownership
Funds ownership: 0.04% → 0.04% (-0%)
9% less funds holding
Funds holding: 77 → 70 (-7)
30% less capital invested
Capital invested by funds: $25M → $17.5M (-$7.46M)
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
61% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 33
Holders
70
Holders Change
-7
Holders Change %
-9.09%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
13
Reduced
33
Closed
12
Calls
$260K
Puts
$226K
Net Calls
+$34K
Net Calls Change
+$357K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$182K |
| 2 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
+$41.8K |
| 3 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$35.4K |
| 4 |
Charles Schwab
San Francisco,
California
|
+$22.6K |
| 5 |
US Bancorp
Minneapolis,
Minnesota
|
+$18K |
